Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease (Q81796868)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18710355%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

review article

1 reference

title

Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18710355%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

3

Lisbeth A Welniak

0 references

William J. Murphy

series ordinal

4

object named as

William J Murphy

0 references

author name string

Minghui Li

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18710355%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Kai Sun

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18710355%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18710355%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

12 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18710355%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18710355%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18710355%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

2305-2316

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18710355%20AND%20SRC:MED&resulttype=core&format=json

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

12 January 2020

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

CD28-specific antibody prevents graft-versus-host disease in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Janus kinase 3 inhibitor WHI-P131/JANEX-1 prevents graft-versus-host disease but spares the graft-versus-leukemia function of the bone marrow allografts in a murine bone marrow transplantation model

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Acute graft-versus-host disease does not require alloantigen expression on host epithelium

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Interleukin 7 worsens graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1 alpha (CCL3) after allogeneic BMT in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Role of CXCR3-induced donor T-cell migration in acute GVHD

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Pathophysiology of acute graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

LPAM (α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Delaying acute graft-versus-host disease in mouse bone marrow transplantation by treating donor cells with antibodies directed at l-selectin and alpha4-integrin prior to infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

A novel triterpenoid induces transforming growth factor beta production by intraepithelial lymphocytes to prevent ileitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Donor APCs are required for maximal GVHD but not for GVL

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Infliximab treatment for steroid-refractory acute graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Stimulation of Host NKT Cells by Synthetic Glycolipid Regulates Acute Graft-versus-Host Disease by Inducing Th2 Polarization of Donor T Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Denileukin diftitox: a concise clinical review

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

CCR6 regulates CD4+ T-cell-mediated acute graft-versus-host disease responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Host-residual invariant NK T cells attenuate graft-versus-host immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Efficacy of the interleukin-2 receptor antagonist basiliximab in steroid-refractory acute graft-versus-host disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Protective conditioning for acute graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: retrospective analysis and comparison with other interleukin-2 receptor antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

CCR2 is required for CD8-induced graft-versus-host disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Update on the management of acute graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Therapy for severe refractory acute graft-versus-host disease with basiliximab, a selective interleukin-2 receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Management of acute graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

The synthetic triterpenoid, CDDO, suppresses alloreactive T cell responses and reduces murine early acute graft-versus-host disease mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Infliximab for GVHD therapy in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Prevention of graft-versus-host disease by anti IL-7Ralpha antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Importance of interleukin-7 in the development of experimental graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Involvement of alpha 1 and alpha 4 integrins in gut mucosal injury of graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18710355

12 December 2020

10.1517/14656566.9.13.2305

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18710355%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18710355%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

PubMed publication ID

18710355

1 reference